Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 9/20 | 0.58 |
| ▸ | NOS3 | P29474 | 7/20 | 0.58 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.48 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.48 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.48 |
| ▸ | PLAU | P00749 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NOS2 | P35228 | 2/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4857038 | 1.00 | NOS1 (0.58) | NOS1NOS3SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4853071 | 0.85 | CYP2D6 (0.64) | NOS1NOS3SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4864124 | 0.83 | NOS3 (0.58) | NOS1NOS3SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4852965 | 0.83 | NOS1 (0.58) | NOS1NOS3SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4856119 | 0.83 | NOS3 (0.58) | NOS1NOS3SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4857014 | 0.83 | MEN1 (0.66) | NOS1NOS3SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4863419 | 0.83 | NOS1 (0.56) | NOS1NOS3SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4861629 | 0.81 | NOS3 (0.54) | NOS1NOS3CYP2D6HIF1AMEN1 | |
| SCHEMBL4860016 | 0.81 | NOS3 (0.54) | NOS1NOS3SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4861886 | 0.81 | NOS3 (0.54) | NOS1NOS3CYP2D6HIF1ANOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7365069-B2 | Pyrimidone derivatives | BEXEL PHARMACEUTICALS INC. (US) | 2008-04-29 | — | — | US | disclosed |
| US-20040259891-A1 | Novel pyrimidon derivatives | ORCHID CHEMICAL & PHARMACEUTICALS LIMITED (IN) | 2004-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040259891-A1 | Novel pyrimidon derivatives | TYMS, TPMT, TYMP | NOS1 3074/4885NOS3 3830/4885SLC22A2 1157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.